UNIVERSITY OF CALIFORNIA-LOS ANGELES, BOARD OF REGENTS
$109M in claimed savings from 5 terminated grants
Total grant value: $406M
Agencies involved: Department of Health and Human Services
Total Grants
5
Terminated by DOGE
Total Grant Value
$406.351M
Originally awarded
Total Claimed Savings
$109.017M
From terminations
Showing 5 of 5 grants
Terminated Grants
| Agency ↕️ | Grant Value ↕️ | Claimed Savings ↓ | Date ↕️ | Description | Link |
|---|---|---|---|---|---|
| Department of Health and Human Services | $197.887M | $45.258M | 3/23/2025 | Abstract This supplement will support ACTIV-2D ACTIV-2D is a master protocol to evaluate the safety and efficacy of investigational agents for the treatment of symptomatic non-hospitalized adults with SARS-CoV-2 infection. The protocol is a phase III multicenter, randomized, double blind trial to ev | N/A |
| Department of Health and Human Services | $170.882M | $43.904M | 3/23/2025 | Abstract This supplement will support ACTIV-2D ACTIV-2D is a master protocol to evaluate the safety and efficacy of investigational agents for the treatment of symptomatic non-hospitalized adults with SARS-CoV-2 infection. The protocol is a phase III multicenter, randomized, double blind trial to ev | N/A |
| Department of Health and Human Services | $20.566M | $11.037M | 3/23/2025 | Abstract This supplement will support ACTIV-2D ACTIV-2D is a master protocol to evaluate the safety and efficacy of investigational agents for the treatment of symptomatic non-hospitalized adults with SARS-CoV-2 infection. The protocol is a phase III multicenter, randomized, double blind trial to ev | N/A |
| Department of Health and Human Services | $11M | $6.831M | 3/23/2025 | RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) Research - 2022 | N/A |
| Department of Health and Human Services | $6.015M | $1.988M | 3/23/2025 | METABOLIC AND EPIGENETIC REPROGRAMMING OF VITAL ORGANS IN SARS-COV-2 INDUCED SYSTEMIC TOXICITY - PROJECT SUMMARY/ABSTRACT SARS-COV-2 PRIMARILY AFFECTS THE RESPIRATORY SYSTEM BUT EXTRA-PULMONARY MANIFESTATIONS IN INDIVIDUALS WITH COVID-19 ARE COMMONLY SEEN. ALL MAJOR ORGAN SYSTEMS HAVE BEEN REPORTED | N/A |